Compton Capital Management’s Biogen BIIB Stock Holding History

Compton Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-715	Closed	-$202K	–	162
2021 Q3	$202K	Sell	715 -50	-7%	-$16.4K	0.06%	156
2021 Q2	$265K	Hold	765	–	–	0.08%	145
2021 Q1	$214K	Buy	+765	New	+$206K	0.07%	153
2020 Q4	–	Sell	-765	Closed	-$217K	–	153
2020 Q3	$217K	Buy	+765	New	+$213K	0.08%	128
2020 Q2	–	Sell	-665	Closed	-$210K	–	129
2020 Q1	$210K	Sell	665 -130	-16%	-$39.5K	0.1%	121
2019 Q4	$236K	Buy	+795	New	+$221K	0.09%	129
2019 Q1	–	Sell	-793	Closed	-$239K	–	131
2018 Q4	$239K	Buy	793 +30	+4%	+$9.57K	0.11%	125
2018 Q3	$270K	Hold	763	–	–	0.11%	130
2018 Q2	$221K	Buy	763 +25	+3%	+$7.03K	0.09%	137
2018 Q1	$202K	Sell	738 -270	-27%	-$83.8K	0.09%	150
2017 Q4	$321K	Buy	+1,008	New	+$323K	0.14%	124

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Compton Capital Management's BIIB Position: Q4 2021 in Review

Compton Capital Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 715 shares — an estimated $202K sold.

Compton Capital Management first reported a position in BIIB in Q4 2017 and held it in 11 quarters. The position peaked at $321K in Q4 2017. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Compton Capital Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Compton Capital Management sold 715 Biogen shares in Q4 2021, an estimated $202K.
Compton Capital Management first reported a position in Biogen in Q4 2017 and held it in 11 quarters.
Compton Capital Management's Biogen position peaked at $321K in Q4 2017.
1,010 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Compton Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.